Patel Sanjiv's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Jan 7, 2026
- Accession no.
- 0001193125-26-006328
- Filed
- Jan 7, 2026
- Trade date
- Dec 31, 2025-Jan 6, 2026
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $337.6K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel SanjivCIK 0001816210 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Common Stock | AGrant or awardAcquired | +994 | $2.99 | +$2,972.06 | 704,209 | Direct | |
| Jan 6, 2026 | Common Stock | SSaleDisposed | −43,168 | $7.82 | −$337,573.76 | 661,041 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.